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Prions: Portable prion domains
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Self-propagating abnormal proteins, prions, have been
identified in yeast; asparagine/glutamine-rich ‘prion
domains’ within these proteins can inactivate the linked
functional domains; new prion domains and reporters
have been used to make ‘synthetic prions’, leading to
discoveries of new natural prions.
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The term ‘prion’ means infectious protein, a concept
originating in studies of the mammalian transmissible
spongiform encephalopathies (TSEs), diseases believed to
be caused by a self-propagating alteration of the PrP protein
(reviewed in [1–3]). In yeast, an infectious protein must,
like a yeast virus, be a non-chromosomal genetic element
that is transferred by cytoplasmic mixing [4]. To distinguish
a prion from a virus or plasmid, three genetic criteria were
proposed: first, if the prion can be ‘cured’, then it should
arise again at some low frequency in the cured strain;
second, overproduction of the protein should increase the
frequency with which the prion arises de novo; and third, the
gene encoding the protein should be necessary for propaga-
tion of the prion, and mutation of that gene should cause
the same phenotype as the presence of the prion [4].
Two non-chromosomal genetic elements in the budding
yeast Saccharomyces cerevisiae, [URE3] and [PSI+], satisfy
these criteria for being prion forms of the proteins Ure2p
and Sup35p, respectively [4]. In their normal states, Ure2p
is a regulator of nitrogen catabolism [5], while Sup35p is a
subunit of the translation termination factor [6,7]. Abundant
supporting evidence confirms the assignment of [URE3]
and [PSI+] as prions. For example, Ure2p and Sup35p are
protease-resistant in extracts of prion-containing cells [8,9],
and aggregated in [URE3] and [PSI+] cells [10,11]. It is
truly the protein whose overproduction induces the de novo
appearance of the prions, and not the mRNAs or a high
copy number of the genes [12,13]. Another prion, [Het-s] of
the filamentous fungus, Podospora anserina has also been
found using the same genetic criteria [14]. The [Het-s]
prion is of particular interest, as it is clearly necessary for a
normal function of the fungal cells — heterokaryon incom-
patibility (reviewed in [15]).
Ure2p and Sup35p can each be divided into an amino-
terminal ‘prion’ domain and a carboxy-terminal functional
domain [8,16]. Overproduction of either prion domain can
induce prion formation in trans; furthermore, each prion
domain is necessary in cis for a protein to be functionally
inactivated by a prion. In fact, the prion domains can
propagate [URE3] [13] and [PSI+] [16] without an attached
functional domain (Figure 1). Both prion domains are very
rich in asparagine and glutamine residues, and these
residues are critical for the prion function [17,18].
However, neither PrP, involved in the TSEs, nor the
HET-s protein responsible for the [Het-s] prion, have
asparagine/glutamine-rich regions. Remarkably, in both
Ure2p and HET-s, it has been possible to identify two
non-overlapping regions, either of which will induce the
de novo appearance of the respective prion when
overproduced [18,19]. The amino-terminal prion domain
of HET-s is only 25 residues in length.
How general is the prion phenomenon? Two other non-
Mendelian genetic elements of S. cerevisiae have recently
been suggested to be prions, but for neither is the evidence
yet conclusive. These are [PIN+], a genetic element neces-
sary for [PSI+] prion induction by overproduction of full-
length Sup35p [20], and [KIL-d], a cytoplasmic genetic
element affecting the expression and propagation of the
Figure 1
Prion-domain specificity in prion propagation: homology governs the
species barrier. Proteins A and B can each form prions. The ‘solo’
prion domain can form and propagate a prion in isolation from the rest
of the protein (inset). The B–A hybrid protein with the B prion domain
and A functional domain can join Prion B filaments, but not Prion A
filaments. Here the A functional domain is acting as a reporter of B
prion activity. The selectivity of cofilament formation is analogous to
crystal formation.
bb10i02.qxd  10/5/00  9:02 am  Page R335
double-stranded RNA ‘killer’ viruses [21,22]. Recently,
two new approaches to finding prion domains have been
developed. Both are based on the notion that prion domains
and the functional domains they affect can be swapped.
One method is to examine the amino termini of homologs
of Sup35p to determine whether they have prion-promot-
ing activity [23–25]. Sup35p homologs from the yeasts
Pichia methanolica, Pichia pastoris, Candida albicans,
Kluyveromyces lactis, Saccharomycodes ludwigii and Zygosaccha-
romyces rouxii all have carboxyl termini highly homologous
to that of S. cerevisiae Sup35p. The amino termini are less
homologous, but retain the high content of glutamine,
asparagine and glycine and the imperfect oligopeptide
repeats found in the S. cerevisiae protein [24,26]. 
The potential prion activities of these proteins were
tested in S. cerevisiae, using fusions of the foreign amino-
terminal domains to the functional carboxy-terminal part
of the S. cerevisiae protein. The P. methanolica–S. cerevisiae
hybrid protein could efficiently replace the essential
Sup35 protein in its role in translation termination [23,25].
Overexpression of this hybrid protein induced the appear-
ance of clones in which translation termination was ineffi-
cient (observed as an increase in the suppression of
nonsense mutations). The [PSI+]-like trait of these strains
was infectious via cytoplasmic transfer — like the known
yeast viruses and prions — and could be cured by deletion
of the heat-shock protein Hsp104 or growth in low con-
centrations of guanidine. This new non-chromosomal
genetic element is denoted [PSI+PS] to recall the hybrid
character of its protein. The hybrid protein is aggregated
in [PSI+PS] strains, is partially protease-resistant in
extracts, and can promote the co-aggregation of the normal
form of the protein in vitro [25]. These observations make
it clear that the hybrid protein can be a prion quite similar
to [PSI+]. Hybrid proteins with amino termini from C. albi-
cans and K. lactis Sup35 proteins also showed properties
expected of [PSI+]-like prions [24].
These hybrids have also been used to examine the
‘species barrier’ phenomenon in yeast (Figure 1).
Although many mammals spontaneously develop TSEs,
transmission between species is delayed, or in many cases
completely blocked because of differences between the
sequences of the PrP proteins [27,28]. The same phenom-
enon has been demonstrated using the hybrid Sup35 pro-
teins in yeast [23–25]. The inactivation and aggregation of
one hybrid was found to be independent of that of
another, although one study detected low-level cross-
induction of prion formation [23]. Santoso et al. [24] local-
ized the specificity region of the prion domain to the
amino-terminal 39 residues, the same region that this
group showed was critical for prion propagation [17]. 
What is the nature of the species barrier? Both Sup35p and
Ure2p form amyloid in vitro, a reaction directed in each
case by the prion domains of the proteins [29–31]. If we
view the prions as amyloid — a kind of linear crystal [32]
— then the species barrier is simply a reflection of the
well-known interference with crystal formation of similar,
but distinct molecules. Part of the the species barrier in
mammalian TSEs involves the normal cellular form of the
prion protein, PrPC, of one species interfering with infec-
tion by the scrapie form, PrPSc, of another species [28], an
effect expected from the crystal model that has not yet
been documented in yeast.
The second new approach to finding new prion domains
exploits the fact that known yeast prion domains are
asparagine–glutamine rich. Following this lead, the effects
have been tested of fusing asparagine/glutamine-rich
domains from other proteins to the known prion-sensitive
functional domain of Sup35p [24,33]. One such domain
was from the protein encoded by the S. cerevisiae gene
YPL226w, dubbed New1p [24], while another was from
the product of the gene YCL028w, named Rnq1p for rich
in N (asparagine) and Q (glutamine) residues [33]. Each of
these domains gave the Sup35p carboxy-terminal domain
prion character. Rnq1p was shown to have alternative
soluble and aggregated states in vivo, with the aggregated
state the infectious form [33].
Although the carboxy-terminal domains of Sup35p and
Ure2p have virtues as tools to test potential prion domains,
they are not necessarily ideal, and it is also of interest to
know what proteins can be sensitive to prion inactivation. Li
and Lindquist [34] have approached this aspect by making a
fusion of the Sup35p prion domain to the glucocorticoid
receptor, in cells whose synthesis of b -galactosidase is regu-
lated by the glucocorticoid receptor. The Sup35p–glucocor-
ticoid receptor hybrid behaved like a prion, with the
glucocorticoid receptor activity nearly eliminated by the
presence of [PSI+]. In contrast, a fusion of the Ure2p prion
domain to b -galactosidase did not lead to prion inactivation
of the enzyme [8]. This suggests that proteins whose activ-
ity depends only on interaction with a small molecule may
be unaffected by a prion, while those which must interact
with another macromolecule or migrate to another compart-
ment are better candidates as prion reporters.
These findings are an important step toward the goal of
finding new prions. They show that the modular approach
to isolation of prion domains is feasible. Are these already
new prions? Some are, but others are not yet clear. A prion
is infectious and infectivity for yeast prions and viruses
means transfer to another cell by cytoplasmic mixing. Of
course, aggregation is not necessarily a sign of a prion, nor
need prions be aggregated. Not all fibrils are amyloid, and
not all amyloidoses are infectious. The Ure2p [8] and
Sup35p [35] prion domains are both dramatically
stabilized by the normal carboxy-terminal domains of the
respective proteins. Some regions capable of acting as
R336 Current Biology Vol 10 No 9
bb10i02.qxd  10/5/00  9:02 am  Page R336
prion domains in isolation from their normal protein
environment may be incapable of doing so normally. This
may be analogous to the finding that transcription activa-
tion domains are acidic regions and many acidic protein
regions unrelated to transcription activators can still carry
out this role [36]. 
In the future, searches for new prion domains will not be
limited to asparagine/glutamine-rich segments. It is
expected that ‘prion banks’ could be screened to detect
prion domains from any organism. The candidate domains
will, however, have to be further examined in their
natural protein environment to determine whether they
are parts of true prions, or simply segments that, out of
context, can aggregate.
References
1. Prusiner SB: Prions. Proc Natl Acad Sci USA 1998, 95:13363-13383.
2. Weissmann C: Molecular genetics of transmissible spongiform
encephalopathies. J Biol Chem 1999, 274:3-6.
3. Caughey B, Chesebro B: Prion protein and the transmissible
spongiform encephalopathies. Trends Cell Biol 1997, 7:56-62.
4. Wickner RB: Evidence for a prion analog in S. cerevisiae: the
[URE3] non-Mendelian genetic element as an altered URE2 protein.
Science 1994, 264:566-569.
5. Magasanik B: Regulation of nitrogen utilization. In The molecular and
cellular biology of the yeast Saccharomyces. Edited by Jones EW,
Pringle JR, Broach JR. Cold Spring Harbor, NY: Cold Spring Harbor
Laboratory Press; 1992:283-317.
6. Zhouravleva G, Frolova L, LeGoff X, LeGuellec R, Inge-Vectomov S,
Kisselev L, Philippe M: Termination of translation in eukaryotes is
governed by two interacting polypeptide chain release factors,
eRF1 and eRF3. EMBO J 1995, 14:4065-4072.
7. Stansfield I, Jones KM, Kushnirov VV, Dagkesamanskaya AR,
Poznyakovski AI, Paushkin SV, Nierras CR, Cox BS, Ter-Avanesyan MD,
Tuite MF: The products of the SUP45 (eRF1) and SUP35 genes
interact to mediate translation termination in Saccharomyces
cerevisiae. EMBO J 1995, 14:4365-4373.
8. Masison DC, Wickner RB: Prion-inducing domain of yeast Ure2p
and protease resistance of Ure2p in prion-containing cells.
Science 1995, 270:93-95.
9. Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD:
Propagation of the yeast prion-like [psi+] determinant is mediated
by oligomerization of the SUP35-encoded polypeptide chain
release factor. EMBO J 1996, 15:3127-3134.
10. Patino MM, Liu J-J, Glover JR, Lindquist S: Support for the prion
hypothesis for inheritance of a phenotypic trait in yeast. Science
1996, 273:622-626.
11. Edskes HK, Gray VT, Wickner RB: The [URE3] prion is an
aggregated form of Ure2p that can be cured by overexpression of
Ure2p fragments. Proc Natl Acad Sci USA 1999, 96:1498-1503.
12. Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG,
Liebman SW: Genesis and variability of [PSI] prion factors in
Saccharomyces cerevisiae. Genetics 1996, 144:1375-1386.
13. Masison DC, Maddelein M-L, Wickner RB: The prion model for
[URE3] of yeast: spontaneous generation and requirements for
propagation. Proc Natl Acad Sci USA 1997, 94:12503-12508.
14. Coustou V, Deleu C, Saupe S, Begueret J: The protein product of
the het-s heterokaryon incompatibility gene of the fungus
Podospora anserina behaves as a prion analog. Proc Natl Acad
Sci USA 1997, 94:9773-9778.
15. Begueret J, Turq B, Clave C: Vegetative incompatibility in
filamentous fungi: het genes begin to talk. Trends Genet 1994,
10:441-446.
16. TerAvanesyan A, Dagkesamanskaya AR, Kushnirov VV, Smirnov VN:
The SUP35 omnipotent suppressor gene is involved in the
maintenance of the non-Mendelian determinant [psi+] in the
yeast Saccharomyces cerevisiae. Genetics 1994, 137:671-676.
17. DePace AH, Santoso A, Hillner P, Weissman JS: A critical role for
amino-terminal glutamine/asparagine repeats in the formation
and propagation of a yeast prion. Cell 1998, 93:1241-1252.
18. Maddelein M-L, Wickner RB: Two prion-inducing regions of Ure2p
are non-overlapping. Mol Cell Biol 1999, 19:4516-4524.
19. Coustou V, Deleu C, Saupe SJ, Begueret J: Mutational analysis of
the [Het-s] prion analog of Podospora anserina: a short
N-terminal peptide allows prion propagation. Genetics 1999,
153:1629-1640.
20. Derkatch IL, Bradley ME, Zhou P, Chernoff YO, Liebman SW:
Genetic and environmental factors affecting the de novo
appearance of the [PSI+] prion in Saccharomyces cerevisiae.
Genetics 1997, 147:507-519.
21. Wickner RB: Mutants of the killer plasmid of Saccharomyces
cerevisiae dependent on chromosomal diploidy for expression
and maintenance. Genetics 1976, 82:273-285.
22. Talloczy Z, Menon S, Neigeborn L, Leibowitz MJ: The [KIL-d]
cytoplasmid genetic element of yeast results in epigenetic
regulation of viral M double-stranded RNA gene expression.
Genetics 1998, 150:21-30.
23. Chernoff YO, Galkin AP, Lewitin E, Chernova TA, Newnam GP,
Belenkly SM: Evolutionary conservation of prion-forming abilities
of the yeast Sup35 protein. Mol Microbiol 2000, 35:865-876.
24. Santoso A, Chien P, Osherovich LZ, Weissman JS: Molecular basis
of a yeast prion species barrier. Cell 2000, 100:277-288.
25. Kushnirov VV, Kochneva-Pervukhova NV, Cechenova MB, Frolova NS,
Ter-Avanesyan MD: Prion properties of the Sup35 protein of yeast
Pichia methanolica. EMBO J 2000, 19:324-331.
26. Kushnirov VV, Ter-Avanesyan MD, Didichenko SA, Smirnov VN,
Chernoff YO, Derkach IL, Novikova ON, Inge-Vechtomov SG,
Neistat MA, Tolstorukov II: Divergence and conservation of SUP2
(SUP35) gene of yeasts Pichia pinus and Saccharomyces
cerevisiae. Yeast 1990, 6:461-472.
27. Pattison IH: Experiments with scrapie and with special reference
to the nature of the agent and the pathology of the disease. In
Slow, Latent and Temperate Virus Infection. Edited by Gajdusek DC,
Gibbs JCJ, Alpers M. Washington, DC: US Government Printing
Office; 1965: 249-257.
28. Prusiner SB, Scott M, Foster D, Pan K-M, Groth D, Mirenda C,
Torchia M, Yang S-L, Serban D, Carlson GA, Hoppe PC, Westaway D,
DeArmond SJ: Transgenic studies implicate interactions between
homologous PrP isoforms in scrapie prion replication. Cell 1990,
63:673-686.
29. King C-Y, Tittmann P, Gross H, Gebert R, Aebi M, Wuthrich K:
Prion-inducing domain 2-114 of yeast Sup35 protein transforms
in vitro into amyloid-like filaments. Proc Natl Acad Sci USA 1997,
94:6618-6622.
30. Glover JR, Kowal AS, Shirmer EC, Patino MM, Liu J-J, Lindquist S:
Self-seeded fibers formed by Sup35, the protein determinant of
[PSI+], a heritable prion-like factor of S. cerevisiae. Cell 1997,
89:811-819.
31. Taylor KL, Cheng N, Williams RW, Steven AC, Wickner RB: Prion
domain initiation of amyloid formation in vitro from native Ure2p.
Science 1999, 283:1339-1343.
32. Lansbury PT, Caughey B: The chemistry of scrapie infection:
implications of the ‘ice 9’ metaphor. Curr Biol 1995, 2:1-5.
33. Sondheimer N, Lindquist S: Rnq1: an epigenetic modifier of protein
function in yeast. Mol Cell 2000, 5:163-172.
34. Li L, Lindquist S: Creating a protein-based element of inheritance.
Science 2000, 287:661-664.
35. Kochneva-Pervukhova NV, Poznyakovski AI, Smirnov VN, Ter-
Avanesyan MD: C-terminal truncation of the Sup35 protein
increases the frequency of de novo gneration of a prion-based
[PSI+] determinant in Saccharomyces cerevisiae. Curr Genet
1998, 34:146-151.
36. Ruden DM, Ma J, Li Y, Wood K, Ptashne M: Generating yeast
transcriptional activators containing no yeast protein sequences.
Nature 1991, 350:250-252.
Dispatch R337
bb10i02.qxd  10/5/00  9:02 am  Page R337
